A Study With an Open-Label Active Control to Evaluate the Potential of Nestorone® to Delay Cardiac Repolarization in Healthy Female Volunteers
Condition(s):HealthyLast Updated:August 15, 2017Completed
Hide Studies Not Open or Pending
Condition(s):HealthyLast Updated:August 15, 2017Completed
Condition(s):Heart Valve Diseases; Parkinson’s Disease; Pergolide; FibrosisLast Updated:September 20, 2007Completed
Condition(s):Heart Failure, DiastolicLast Updated:September 3, 2019Terminated
Condition(s):Spinal Cord Injuries; Cardiovascular Abnormalities; Cerebrovascular Disease; Sequelae; Cognitive ImpairmentLast Updated:February 14, 2024Suspended
Condition(s):Coronary Heart DiseaseLast Updated:June 25, 2018Completed
Condition(s):Left Ventricular HypertrophyLast Updated:October 27, 2017Completed
Condition(s):Valvular SurgeryLast Updated:January 27, 2022Recruiting
Condition(s):Heart Failure; AtherosclerosisLast Updated:December 11, 2018Unknown status
Condition(s):Parkinson DiseaseLast Updated:June 21, 2012Completed
Condition(s):Chronic Heart FailureLast Updated:February 10, 2011Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.